reference/3096022

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3096022

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	299
issn	1557-9190
issueIdentifier	5
pageRange	294-299
publicationName	Clinical Lymphoma and Myeloma
startingPage	294
bibliographicCitation	Offidani M, Corvatta L, Polloni C, Piersantelli MN, Galieni P, Visani G, Alesiani F, Catarini M, Brunori M, Burattini M, Centurioni R, Ferranti M, Giuliodori L, Candela M, Mele A, Marconi M, Leoni P. Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy. Clin Lymphoma Myeloma. 2008 Oct;8(5):294–9. doi: 10.3816/clm.2008.n.041. PMID: 18854284.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41348f21d33f01966d550a174eca4271 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fccfbb1b6e155d924e871fd8a1179d01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94c284ab7c1bbb975b11eb3eeb3c04b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e4683eee6dda36d269a0aed7dbe9d0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12d220bb1089810884f9c1f9ef0a1b81 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f75204f09e03fd6a7ec6e83fe36d54ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b72269d0820152a51e3ef544cc7a692 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55fd53d800df954952dcfd8f1cb7e9a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21cc87014c495b8ee80fd01e0b0df3a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_490f41925603c1ea5ee4ca6dcc165912 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef67a3a315f792eab43aaed4013a71f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cade45cdd5816cb6b9d0aad5fb4582c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bd44da50d51907ea2c57adfa4a3d878 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80ba75c81075af17a88f93969cd529cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a056d3c23e851236b5edf1ea1a62f893 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f541b1aa9d66796cada9ef3b153d31e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a313f4f174fd19de833a0427551e14cf
date	200810
identifier	https://pubmed.ncbi.nlm.nih.gov/18854284 https://doi.org/10.3816/clm.2008.n.041
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32602 https://portal.issn.org/resource/ISSN/1557-9190
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy
discusses	http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0028312 http://id.nlm.nih.gov/mesh/M0003122 http://id.nlm.nih.gov/mesh/M0023752
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000628 http://id.nlm.nih.gov/mesh/D009101Q000097 http://id.nlm.nih.gov/mesh/D015415Q000032 http://id.nlm.nih.gov/mesh/D002097Q000032 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000473 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D018943Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D013792Q000008 http://id.nlm.nih.gov/mesh/D009101Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6927 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432

Total number of triples: 65.